Back to Journals » Reports in Medical Imaging » Volume 2

Evaluation of an anthropomorphic male pelvic phantom for image-guided radiotherapy

Authors B Schaly, V Varchena, P Au, G Pang

Published 24 July 2009 Volume 2009:2 Pages 69—78

DOI https://doi.org/10.2147/RMI.S6114

Review by Single-blind

Peer reviewer comments 3

B Schaly1, V Varchena2, P Au3, G Pang3,4

1Grand River Regional Cancer Centre, Kitchener, ON, Canada; 2CIRS Inc., Norfolk, VA, USA; 3Odette Cancer Centre, Toronto, ON, Canada; 4Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Toronto, ON, Canada

Abstract: Soft-tissue imaging in the treatment room is one of the main challenges faced today in high precision radiotherapy. The objective of this work is to evaluate a new anthropomorphic male pelvic phantom (CIRS Inc., Norfolk, VA, USA) that can be used in a radiotherapy department to assess the ability of an X-ray imaging system for imaging soft-tissue targets in the treatment room. To this end, we evaluated the tissue-equivalency of the phantom materials in terms of the linear attenuation and energy absorption coefficients. X-ray computed tomography (CT) images of the phantom were also obtained and compared with that of patients. Our results demonstrated that the male pelvic phantom is a good representation of actual prostate cancer patients and can be a valuable tool for image-guided radiotherapy.

Keywords: image-guided radiotherapy, X-ray imaging, anthropomorphic phantom

PACS numbers: 87.56.Fc, 87.59.bd, 87.85.Lf

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Optimal delivery of male breast cancer follow-up care: improving outcomes

Ferzoco RM, Ruddy KJ

Breast Cancer: Targets and Therapy 2015, 7:371-379

Published Date: 23 November 2015

Brachytherapy in the treatment of cervical cancer: a review

Banerjee R, Kamrava M

International Journal of Women's Health 2014, 6:555-564

Published Date: 28 May 2014

Clinical epidemiology of epithelial ovarian cancer in the UK

Doufekas K, Olaitan A

International Journal of Women's Health 2014, 6:537-545

Published Date: 23 May 2014

Ulcerative colitis six years after colon cancer: only a coincidence?

Sakellakis M, Makatsoris T, Gkermpesi M, Peroukidis S, Kalofonos H

International Medical Case Reports Journal 2014, 7:85-88

Published Date: 29 April 2014

Targeting γ-secretase in breast cancer

Han J, Shen Q

Breast Cancer: Targets and Therapy 2012, 4:83-90

Published Date: 21 June 2012

How to reduce your cancer risk: mechanisms and myths

Nahleh Z, Bhatti NS, Mal M

International Journal of General Medicine 2011, 4:277-287

Published Date: 8 April 2011